Skip to main content

UBS Group AG

Position in SNGX — Soligenix, Inc.

CIK 1610520 ZURICH, V8

Position in SNGX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$2,768
-$42,810 QoQ
Shares Held
2,346
-93.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SNGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,747,178,871 across 561 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in SNGX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,768 2,346
2025-12-31 $45,578 34,014
2025-09-30 $212 183
2025-06-30 $25,443 19,423
2025-03-31 $22,507 10,469
2024-12-31 $845 313
2024-06-30 $16,075 6,231
2024-03-31 $857 1,429
2023-06-30 $1,255 1,794
2022-12-31 $2,046 4,547
2022-09-30 $6,449 14,657
2022-03-31 $4,726 6,475
2021-12-31 $14,682 22,246
2021-09-30 $8,583 8,098
2021-03-31 $3,040 1,988
2020-12-31 $101 79
2020-09-30 $141 79
2020-06-30 $7,143 3,386
2020-03-31 $132 79